Evidence map›Paper›PMID 38667455›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Cristina Carranza-Rodríguez, Margarita Bolaños-Rivero, José-Luis Pérez-Arellano

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. HumanMicroorganisms · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Cristina Carranza-RodríguezUniversity of Las Palmas de Gran Canaria, Spain and Research Institute of Biomedical and Health Sciences, 35016 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-2768-0072
Margarita Bolaños-RiveroMicrobiology Division, Complejo Hospitalario Universitario Insular Materno Infantil, 35016 Las Palmas de Gran Canaria, Spain.
José-Luis Pérez-ArellanoUniversity of Las Palmas de Gran Canaria, Spain and Research Institute of Biomedical and Health Sciences, 35016 Las Palmas de Gran Canaria, Spain.
Universidad de Las Palmas de Gran Canaria · ESHospital Universitario Insular de Gran Canaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A prior investigation in 1993 identified a high seroprevalence of toxoplasmosis (63%) in the Canary Islands. This study aims to assess the current prevalence of the disease in diverse population groups. The study was based on a population-scale screening involving 273 residents utilizing

Indexed as

AIDS/HIVCanary Islandshuman toxoplasmosisseroprevalenceSpainToxoplasma gondii

Identifiers

PMID38667455
PMCPMC11049236
OpenAlexW4394748217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.